Related references
Note: Only part of the references are listed.Comparative study of different glycating agents on human plasma and vascular cells
Rashmi S. Tupe et al.
MOLECULAR BIOLOGY REPORTS (2020)
Impact of advanced glycation end products (AGEs) signaling in coronary artery disease
Marinos Kosmopoulos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Increased erythrocyte- and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus
Eugenia Gkaliagkousi et al.
DIABETES & VASCULAR DISEASE RESEARCH (2019)
3-Hydroxykynurenine bound to eye lens proteins induces oxidative modifications in crystalline proteins through a type I photosensitizing mechanism
Felipe Avila et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases
Mariane Lutz et al.
MOLECULES (2019)
Glycated albumin modifies platelet adhesion and aggregation responses
Ioana Soaita et al.
PLATELETS (2017)
Evaluation of methylglyoxal toxicity in human erythrocytes, leukocytes and platelets
Alessandro de Souza Prestes et al.
TOXICOLOGY MECHANISMS AND METHODS (2017)
Evaluation of methylglyoxal toxicity in human erythrocytes, leukocytes and platelets
Alessandro de Souza Prestes et al.
TOXICOLOGY MECHANISMS AND METHODS (2017)
Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin
Saurabh Awasthi et al.
MOLECULAR PHARMACEUTICS (2015)
Glycated Albumin With Loss of Fatty Acid Binding Capacity Contributes to Enhanced Arachidonate Oxygenation and Platelet Hyperactivity: Relevance in Patients With Type 2 Diabetes
Denis Blache et al.
DIABETES (2015)
Kinetics of Glycoxidation of Bovine Serum Albumin by Methylglyoxal and Glyoxal and its Prevention by Various Compounds
Izabela Sadowska-Bartosz et al.
MOLECULES (2014)
Protective mechanisms of adenosine 5′-monophosphate in platelet activation and thrombus formation
Eduardo Fuentes et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Role of multiligand/RAGE axis in platelet activation
Eduardo Fuentes et al.
THROMBOSIS RESEARCH (2014)
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
Mohsen Kerkeni et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster
Eleni N. Tsakiri et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36
Weifei Zhu et al.
BLOOD (2012)
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Jose Luis Ferreiro et al.
CIRCULATION (2011)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
Pyridoxine Improves Platelet Nitric Oxide Synthase Dysfunction Induced by Advanced Glycation End Products in vitro
Yi Han et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2010)
Gender differences in platelet aggregation in healthy individuals
Mohammad Otahbachi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
Advanced glycation end products strongly activate platelets
Thomas Gawlowski et al.
EUROPEAN JOURNAL OF NUTRITION (2009)
Glycated albumin modulates platelet susceptibility to flow induced activation and aggregation
David A. Rubenstein et al.
PLATELETS (2009)
Advanced glycation and ROS: A link between diabetes and heart failure
Armando Rojas et al.
CURRENT VASCULAR PHARMACOLOGY (2008)
Correlation of low molecular weight advanced glycation end products and nitric oxide metabolites with chronic complications in type 1 diabetic patients
Constantina Heltianu et al.
CENTRAL EUROPEAN JOURNAL OF BIOLOGY (2008)
17β-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets
Lu Chen et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Eugene A. Podrez et al.
NATURE MEDICINE (2007)
Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors
Yingjie Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Pyridoxamine analogues scavenge lipid-derived γ-ketoaldehydes and protect against H2O2-mediated cytotoxicity
Sean S. Davies et al.
BIOCHEMISTRY (2006)
Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis
Matthew A. Roberts et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction
JLN Wolfs et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates
S Yokoyama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus
Y Hasegawa et al.
THROMBOSIS RESEARCH (2002)
Increased platelet and erythrocyte external cell membrane phosphatidylserine in type 1 diabetes and microalbuminuria
ST Wahid et al.
DIABETES CARE (2001)
CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products
N Ohgami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
